Advertisement

Archives of Gynecology and Obstetrics

, Volume 284, Issue 5, pp 1073–1079 | Cite as

Umbilical vein oxytocin in the management of retained placenta: an alternative to manual removal of placenta?

  • Pei Shan LimEmail author
  • Surinder Singh
  • Alice Lee
  • Muhammad Abdul Jamil Muhammad Yassin
Materno-fetal Medicine

Abstract

Purpose

Retained placenta is potentially life threatening due to possible complications associated with manual removal. Our aim was to determine whether umbilical vein injection of oxytocin in saline reduces the need for manual removal of placenta.

Methods

This was a randomised controlled trial conducted at a tertiary hospital from December 2002 to March 2004. A total of 61 women delivering singletons, who had no sign of placental separation 20 min after vaginal delivery, were randomised to receive either intra-umbilical oxytocin 100 IU diluted in 30 ml of saline or controlled cord traction only. Manual removal was done if the placenta was not expelled in another 30 min in both arms.

Results

There was a significant reduction in the rate of subsequent manual removal of placenta (30 vs. 67.7%, p < 0.05), incidence of uterine atony (3.3 vs. 25.8%, p < 0.05) and the need for uterotonic agents (33.3 vs. 64.5%, p < 0.05) in the oxytocin group when compared with the control group. No significant differences were found in the need for blood transfusion, uterine curettage, incidence of postpartum haemorrhage and haemoglobin level reduction.

Conclusion

Intra-umbilical vein oxytocin injection is clinically effective for the management of a retained placenta.

Keywords

Intra-umbilical Oxytocin Retained Placenta Umbilical vein 

Notes

Acknowledgments

The authors wish to thank the staffs of the labour suite and the patients who had participated in this study.

Conflict of interest

We declare that we have no conflict of interest.

References

  1. 1.
    Report On The Confidential Enquires Into Maternal Deaths In Malaysia 1997–2000; 1–22. Division of Family Health Development, Ministry of MalaysiaGoogle Scholar
  2. 2.
    Report On The Confidential Enquires Into Maternal Deaths In Malaysia 1995–1996; 47–59. Division of Family Health Development, Ministry of MalaysiaGoogle Scholar
  3. 3.
    Report On The Confidential Enquires Into Maternal Deaths In Malaysia 1994; 31–40. Division of Family Health Development, Ministry of MalaysiaGoogle Scholar
  4. 4.
    Report On The Confidential Enquires Into Maternal Deaths In Malaysia 2001–2005; 1–24. Division of Family Health Development. Ministry of MalaysiaGoogle Scholar
  5. 5.
    Wilken Jensen C, Strøm V, Nielsen MD, Rosenkilde-Gram B (1989) Removing a retained placenta by oxytocin: a controlled study. Am J Obstet Gynecol 161(1):155–156PubMedGoogle Scholar
  6. 6.
    Sivalingam N, Surinder S (2001) Is there a place for intra-umbilical oxytocin for the management of retained placenta? Med J Malays 56(4):451–459Google Scholar
  7. 7.
    Makkonen M, Suonio S, Saarikoski S (1995) Intra-umbilical oxytocin for the management of retained placenta. Int J Gynaecol Obstet 48(2):169–172PubMedCrossRefGoogle Scholar
  8. 8.
    Carroli G, Belizan JM, Grant A, Gonzalez L, Campodonico L, Bergel E (1998) Intra-umbnilical vein injection and retained placenta: evidence from a collaborative large randomised controlled trial. Br J Obstet Gynaecol 105(2):179–185PubMedCrossRefGoogle Scholar
  9. 9.
    Frappell JM, Pearce JM, McParland P (1988) Intra-umbilical vein oxytocin in the management of retained placenta: a random, prospective, double blind, placebo controlled study. J Obstet Gynaecol 8:322–324CrossRefGoogle Scholar
  10. 10.
    Selinger M, MacKenzie I, Dunlop P (1986) Intra-umbilical vein oxytocin in the management of retained placenta: a random, prospective, double blind, placebo controlled study. J Obstet Gynaecol 7:115–117CrossRefGoogle Scholar
  11. 11.
    Weeks AD (2008) The retained placenta. Best Pract Res Clin Obstet Gynaecol 22(6):1103–1117PubMedCrossRefGoogle Scholar
  12. 12.
    Brandt ML (1933) The mechanism and management of the third stage of labour. Am J Obstet Gynecol 25:662–667Google Scholar
  13. 13.
    Ratnam SS, Rauff M (1989) Postpartum haemorrhage and abnormalities of the third stage of labour. In: Chamberlain G (ed) Turnbull’s obstetrics. Churchill Livingstone, London, p 867Google Scholar
  14. 14.
    Carroli G, Bergel E (2009) Umbilical vein injection for management of retained placenta. Cochrane Database Sys Rev (Issue 4). doi: 10.1002/14651858.CD001337. Art. No: CD001337
  15. 15.
    Bider D, Dulitzky M, Goldenberg M, Lipitz S, Mashiach S (1996) Intraumbilical vein injection of prostaglandin F2 alpha in retained placenta. Eur J Obstet Gynecol Reprod Biol 64(1):59–61PubMedCrossRefGoogle Scholar
  16. 16.
    Gazvani MR, Luckas MJ, Drakeley AJ, Emery SJ, Alfirevic Z, Walkinshaw SA (1998) Intraumbilical oxytocin for the management of retained placenta: a randomized controlled trial. Obstet Gynecol 91(2):203–207PubMedCrossRefGoogle Scholar
  17. 17.
    Pipingas A, Hofmeyr GJ, Sesel KR (1993) Umbilical vessel oxytocin administration for retained placenta: in vitro study of various infusion techniques. Am J Obstet Gynecol 168(3):793–795PubMedGoogle Scholar
  18. 18.
    Weeks A, Alia G, Vernon G, Namayanja A, Gosakan R, Majeed T, Hart A, Jafri H, Nardin J, Carroli G, Fairlie F, Raashid Y, Mirembe F, Alfirevic Z (2010) Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial. Lancet 375:141–147PubMedCrossRefGoogle Scholar
  19. 19.
    National Collaborating Centre for Women’s, Children’s Health (NCCWCH) (2007) Intrapartum care. Care of women and their babies during childbirth. RCOG Press, LondonGoogle Scholar
  20. 20.
    WHO (2006) Pregnancy, childbirth, postpartum and newborn care: a guide for essential practice, 2nd edn. WHO, Geneva B11Google Scholar
  21. 21.
    Magann EF, Evans S, Chauhan SP, Lanneau G, Fisk AD, Morrison JC (2005) The length of the third stage of labour and the risk of postpartum haemorrhage. Obstet Gynaecol 105(2):290–293CrossRefGoogle Scholar
  22. 22.
    Spencer PM (1962) Controlled cord traction in management of the third stage of labour. BMJ 1(5294):1728–1732PubMedCrossRefGoogle Scholar
  23. 23.
    Kimbell N (1958) Brandt–Andrew technique of delivery of the placenta. BMJ 1(5064):203–205PubMedCrossRefGoogle Scholar
  24. 24.
    Kristiansen FV, Frost L, Kaspersen P, Moller B (1987) The effect of oxytocin injection into the umbilical vein for the management of the retained placenta. Am J Obstet Gynecol 156:979–980PubMedGoogle Scholar
  25. 25.
    Huber MGP, Wildschut HIJ, Boer K, Kleiverda G, Hoek FJ (1991) Umbilical vein administration of oxytocin for the management of retained placenta: is it effective? Am J Obstet Gynecol 164:1216–1219PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Pei Shan Lim
    • 1
    Email author
  • Surinder Singh
    • 2
  • Alice Lee
    • 3
  • Muhammad Abdul Jamil Muhammad Yassin
    • 1
  1. 1.Department of O&GUniversiti Kebangsaan Malaysia Medical CenterCheras, Kuala LumpurMalaysia
  2. 2.Tropicana Medical CenterPetaling JayaMalaysia
  3. 3.Damansara Fertility CentreJohor BahruMalaysia

Personalised recommendations